Scarica l'app Stockscreener
51.13
4.11%
-2.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CYTK Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$53.32
Aprire:
$52.65
Volume 24 ore:
1.90M
Relative Volume:
1.04
Capitalizzazione di mercato:
$6.12B
Reddito:
$18.47M
Utile/perdita netta:
$-589.53M
Rapporto P/E:
-9.7205
EPS:
-5.26
Flusso di cassa netto:
$-399.80M
1 W Prestazione:
-3.55%
1M Prestazione:
+49.02%
6M Prestazione:
+16.23%
1 anno Prestazione:
-5.42%
Intervallo 1D:
$51.06
$53.28
Intervallo di 1 settimana:
$50.05
$54.22
Portata 52W:
$29.31
$59.39
Cytokinetics Inc Stock (CYTK) Company Profile
Nome
Cytokinetics Inc
Settore
Industria
Telefono
(650) 624-3000
Indirizzo
350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Confronta CYTK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYTK
Cytokinetics Inc
|
51.13 | 6.22B | 18.47M | -589.53M | -399.80M | -5.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cytokinetics Inc Stock (CYTK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Ripresa | Raymond James | Mkt Perform |
| 2025-04-24 | Iniziato | Barclays | Overweight |
| 2025-02-07 | Iniziato | Citigroup | Buy |
| 2025-01-22 | Iniziato | Stifel | Buy |
| 2024-11-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-13 | Downgrade | Goldman | Buy → Neutral |
| 2024-01-24 | Downgrade | UBS | Buy → Neutral |
| 2024-01-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-09 | Iniziato | Goldman | Buy |
| 2023-11-07 | Iniziato | B. Riley Securities | Buy |
| 2023-08-15 | Iniziato | SVB Securities | Outperform |
| 2023-02-17 | Iniziato | BofA Securities | Neutral |
| 2022-12-23 | Reiterato | Needham | Buy |
| 2022-12-20 | Iniziato | Truist | Buy |
| 2022-10-11 | Iniziato | UBS | Buy |
| 2022-01-28 | Iniziato | Goldman | Buy |
| 2021-12-22 | Iniziato | Oppenheimer | Outperform |
| 2021-12-10 | Iniziato | JP Morgan | Overweight |
| 2021-10-07 | Iniziato | Jefferies | Buy |
| 2021-03-12 | Iniziato | Wolfe Research | Outperform |
| 2021-02-18 | Iniziato | Barclays | Overweight |
| 2021-01-20 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-29 | Iniziato | Goldman | Neutral |
| 2020-07-10 | Iniziato | Raymond James | Strong Buy |
| 2020-05-05 | Iniziato | Mizuho | Buy |
| 2020-04-09 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-10 | Ripresa | Morgan Stanley | Equal-Weight |
| 2017-11-22 | Reiterato | Morgan Stanley | Overweight |
| 2017-11-22 | Downgrade | Needham | Strong Buy → Buy |
| 2017-11-21 | Reiterato | H.C. Wainwright | Buy |
| 2017-07-31 | Iniziato | Morgan Stanley | Overweight |
| 2017-03-08 | Iniziato | Rodman & Renshaw | Buy |
| 2017-02-06 | Aggiornamento | Needham | Buy → Strong Buy |
| 2016-12-16 | Iniziato | Cantor Fitzgerald | Overweight |
| 2016-07-28 | Reiterato | Needham | Buy |
| 2015-11-10 | Reiterato | FBR Capital | Outperform |
| 2015-11-09 | Reiterato | ROTH Capital | Buy |
| 2015-07-24 | Reiterato | MLV & Co | Buy |
| 2014-12-31 | Reiterato | ROTH Capital | Buy |
| 2014-11-04 | Aggiornamento | MLV & Co | Hold → Buy |
| 2014-04-28 | Reiterato | Needham | Buy |
Mostra tutto
Cytokinetics Inc Borsa (CYTK) Ultime notizie
Bayforest Capital Ltd Raises Holdings in Cytokinetics, Incorporated $CYTK - MarketBeat
Cytokinetics (NASDAQ:CYTK) EVP Sells 2,000 Shares - MarketBeat
Pentwater Capital Management LP Sells 229,100 Shares of Cytokinetics, Incorporated $CYTK - MarketBeat
Alliancebernstein L.P. Has $61.23 Million Stake in Cytokinetics, Incorporated $CYTK - MarketBeat
Alyeska Investment Group L.P. Has $3.01 Million Stake in Cytokinetics, Incorporated $CYTK - MarketBeat
Levi & Korsinsky Announces an Investigation on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Cytokinetics (CYTK): Is the Current Market Valuation Overlooking the Company’s Long-Term Potential? - Yahoo Finance
Zimmer Partners LP Acquires 44,132 Shares of Cytokinetics, Incorporated $CYTK - MarketBeat
15,991 Shares in Cytokinetics, Incorporated $CYTK Bought by Graham Capital Management L.P. - MarketBeat
Cytokinetics, Incorporated (NASDAQ:CYTK) Receives $75.38 Average PT from Analysts - MarketBeat
Insider Sell: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Why Are These Biotech Stocks Outperforming Their Peers? - CMC Markets
52,321 Shares in Cytokinetics, Incorporated $CYTK Purchased by Cinctive Capital Management LP - MarketBeat
Cutter Capital Management LP Buys Shares of 175,000 Cytokinetics, Incorporated $CYTK - MarketBeat
Cytokinetics at Morgan Stanley Conference: Aficamten’s Launch Strategy - Investing.com
Aug Wrap: Can Cytokinetics Incorporated reach all time highs this yearMarket Activity Summary & Free Long-Term Investment Growth Plans - Lancaster City Council
Eventide Asset Management LLC Purchases 128,548 Shares of Cytokinetics, Incorporated $CYTK - MarketBeat
Cytokinetics Incorporated’s Price Action Aligns with Quant Signals2025 Trading Recap & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Investors Purchase Large Volume of Call Options on Cytokinetics (NASDAQ:CYTK) - MarketBeat
Is Cytokinetics Incorporated a top pick in the sectorJuly 2025 Drop Watch & Risk Controlled Swing Alerts - beatles.ru
Cytokinetics (CYTK) Rockets 40.45% as Aficamten Results Promising - MSN
Redmile Group LLC Sells 10,500 Shares of Cytokinetics, Incorporated $CYTK - MarketBeat
Will earnings trigger a reversal in Cytokinetics Incorporated2025 Key Highlights & Smart Swing Trading Alerts - Newser
Vestal Point Capital LP Buys 240,531 Shares of Cytokinetics, Incorporated $CYTK - MarketBeat
Multi asset correlation models including Cytokinetics Incorporated2025 Price Action Summary & Detailed Earnings Play Alerts - Newser
Is Cytokinetics Incorporated’s ROE strong enough2025 Market Outlook & Daily Growth Stock Tips - خودرو بانک
What’s the analyst consensus on Cytokinetics Incorporated2025 Key Highlights & AI Driven Price Predictions - خودرو بانک
Is Cytokinetics Incorporated stock a good pick for beginners2025 Sector Review & Smart Money Movement Tracker - خودرو بانک
Published on: 2025-09-05 22:58:57 - خودرو بانک
Braveheart licenses Hengrui's heart drug HRS-1893 in $1B deal - BioWorld MedTech
Is Cytokinetics Incorporated stock bottoming outTrade Signal Summary & Safe Capital Allocation Plans - Newser
Cytokinetics patents new MYBPC2 inhibitors - BioWorld MedTech
Cytokinetics shares rise 1.19% premarket after Cantor Global Healthcare Conference fireside chat. - AInvest
Predicting Cytokinetics Incorporated trend using moving averagesJuly 2025 Patterns & Safe Entry Momentum Tips - Newser
Real time social sentiment graph for Cytokinetics IncorporatedMarket Movement Recap & AI Powered Market Entry Strategies - Newser
Updated: Hengrui does another US deal, this time in Cytokinetics' cardio arena - Endpoints News
858,664 Shares in Cytokinetics, Incorporated $CYTK Bought by Paradigm Biocapital Advisors LP - MarketBeat
Using Python tools to backtest Cytokinetics Incorporated strategiesJuly 2025 Sector Moves & Weekly Market Pulse Updates - Newser
Spinal Muscular Atrophy Market Positioned for Accelerated - openPR.com
Will Cytokinetics Incorporated benefit from macro trendsQuarterly Trade Report & Technical Pattern Recognition Alerts - Newser
Cytokinetics Incorporated stock prediction for this weekJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser
How to read the order book for Cytokinetics Incorporated2025 Short Interest & Community Consensus Picks - Newser
How to manage a losing position in Cytokinetics IncorporatedJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser
Movement Recap: Is Cytokinetics Incorporated a top pick in the sector2025 Trading Volume Trends & AI Based Trade Execution Alerts - خودرو بانک
Cytokinetics Gains on Positive Late-Stage Cardiomyopathy Study Results - Yahoo Finance
Cytokinetics: Evercore ISI Group raises PT to $80 from $60, maintains Outperform. - AInvest
Cytokinetics shares fall 1.15% premarket after insider sold shares worth $337,800. - AInvest
Will Cytokinetics Incorporated benefit from rate cutsInsider Selling & Risk Controlled Stock Alerts - خودرو بانک
Understanding Cytokinetics Incorporated’s price movement2025 Biggest Moves & Community Trade Idea Sharing Platform - Newser
Does Cytokinetics Incorporated show high probability of reboundJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - Newser
Can Cytokinetics Incorporated recover in the next quarterMarket Rally & Free Safe Capital Growth Stock Tips - Newser
Cytokinetics Inc Azioni (CYTK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):